TY - JOUR T1 - Key Issues of Venture Capital Investing in Foreign Markets JF - The Journal of Private Equity SP - 47 LP - 54 DO - 10.3905/jpe.2004.412335 VL - 7 IS - 3 AU - Michel Y. Bergeron AU - Marko Savor AU - Lawrence Kryzanowski Y1 - 2004/05/31 UR - https://pm-research.com/content/7/3/47.abstract N2 - The article presents the results of in-depth interviews with key biotechnology executives and emphasizes the issues and challenges American investors face when investing venture capital funds in the Canadian biotechnology sector. The results show that, although capital suppliers feel that the quality of Canadian science is credible and that its biotechnology industry presents interesting investment opportunities, they must be careful to adjust their due diligence procedures to account for the specific characteristics of the Canadian environment. It is argued that specialized U.S. venture capital investors can capitalize on the sectorņs opportunities as long as the key issues are properly addressed. ER -